Hector Gutierrez

1.2k total citations
31 papers, 662 citations indexed

About

Hector Gutierrez is a scholar working on Pulmonary and Respiratory Medicine, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Hector Gutierrez has authored 31 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 7 papers in General Health Professions and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Hector Gutierrez's work include Cystic Fibrosis Research Advances (20 papers), Neonatal Respiratory Health Research (10 papers) and Tracheal and airway disorders (5 papers). Hector Gutierrez is often cited by papers focused on Cystic Fibrosis Research Advances (20 papers), Neonatal Respiratory Health Research (10 papers) and Tracheal and airway disorders (5 papers). Hector Gutierrez collaborates with scholars based in United States, Chile and United Kingdom. Hector Gutierrez's co-authors include Bruce Α. Freeman, Phillip Chumley, Philip M. Farrell, Virginie Scotet, Michael S. Schechter, Gabriela R. Oates, William T. Harris, Simon C. Watkins, Isabella Caniggia and Charles J. Lowenstein and has published in prestigious journals such as Free Radical Biology and Medicine, Ophthalmology and American Journal of Physiology-Lung Cellular and Molecular Physiology.

In The Last Decade

Hector Gutierrez

28 papers receiving 642 citations

Peers

Countries citing papers authored by Hector Gutierrez

Since Specialization

Citations

This map shows the geographic impact of Hector Gutierrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hector Gutierrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hector Gutierrez more than expected).

Fields of papers citing papers by Hector Gutierrez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hector Gutierrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hector Gutierrez. The network helps show where Hector Gutierrez may publish in the future.

Co-authorship network of co-authors of Hector Gutierrez

This figure shows the co-authorship network connecting the top 25 collaborators of Hector Gutierrez. A scholar is included among the top collaborators of Hector Gutierrez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hector Gutierrez. Hector Gutierrez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chalazion and Hordeolum Development in Patients with Cystic Fibrosis on Elexacaftor/Ttezacaftor/Ivacaftor Therapy 2024 ·Ophthalmology ·(unknown), (unknown), (unknown), Hector Gutierrez	0
2	Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome 2023 ·Frontiers in Pediatrics ·(unknown), Elizabeth Baker, (unknown), (unknown), Hector Gutierrez, Jennifer S. Guimbellot	11
3	Mobile health platform for self-management of pediatric cystic fibrosis: Impact on patient-centered care outcomes 2023 ·Journal of Cystic Fibrosis ·Gabriela R. Oates, (unknown), (unknown), (unknown), Andreas Häger, Jennifer S. Guimbellot, (unknown), Hector Gutierrez	5
4	Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis 2021 ·Journal of Cystic Fibrosis ·(unknown), Kevin J. Ryan, Hector Gutierrez, Luz Helena Gutierrez Sanchez, (unknown), Edward P. Acosta, Kim W. Benner, Jennifer S. Guimbellot	15
5	Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis 2020 ·Journal of Cystic Fibrosis ·Gabriela R. Oates, Elizabeth Baker, Steven M. Rowe, Hector Gutierrez, Michael S. Schechter, Wayne J. Morgan, William T. Harris	24
6	Tobacco Smoke Exposure and Socioeconomic Factors are Independent Predictors of Pulmonary Decline in Pediatric Cystic Fibrosis 2019 ·SSRN Electronic Journal ·Gabriela R. Oates, Elizabeth Baker, Steven M. Rowe, Hector Gutierrez, Michael S. Schechter, Wayne J. Morgan, William T. Harris	1
7	Objective Versus Self-Reported Adherence to Airway Clearance Therapy in Cystic Fibrosis 2018 ·Respiratory Care ·Gabriela R. Oates, Irena Štěpáníková, Steven M. Rowe, (unknown), Hector Gutierrez, William T. Harris	11
8	Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening 2016 ·Pediatric Pulmonology ·(unknown), Gabriela R. Oates, Robert A. Oster, (unknown), (unknown), Wynton Hoover, Hector Gutierrez, William T. Harris	7
9	Adherence to airway clearance therapy in pediatric cystic fibrosis: Socioeconomic factors and respiratory outcomes 2015 ·Pediatric Pulmonology ·Gabriela R. Oates, Irena Štěpáníková, (unknown), Hector Gutierrez, William T. Harris	36
10	Spiritual coping predicts 5-year health outcomes in adolescents with cystic fibrosis 2014 ·Journal of Cystic Fibrosis ·Nina Reynolds, Sylvie Mrug, (unknown), (unknown), Kelly R. Wolfe, Hector Gutierrez	23
11	Acute Kidney Injury in Hospitalized Children With Cystic Fibrosis 2014 ·(unknown), (unknown), Neha Patil, Rajesh Koralkar, (unknown), Raymond K. Lyrene, (unknown), Hector Gutierrez, David J. Askenazi	1
12	Rapid Onset of Iatrogenic Adrenal Insufficiency in a Patient with Cystic Fibrosis–Related Liver Disease Treated with Inhaled Corticosteroids and a Moderate CYP3A4 Inhibitor 2011 ·Annals of Pharmacotherapy ·Wynton Hoover, (unknown), (unknown), Tracy L. Jackson, Hector Gutierrez	18
13	Baseline Characteristics and Factors Associated With Nutritional and Pulmonary Status at Enrollment in the Cystic Fibrosis EPIC Observational Cohort 2010 ·Pediatric Pulmonology ·Margaret Rosenfeld, Julia Emerson, Sharon McNamara, (unknown), George Retsch‐Bogart, Gavin R. Graff, Hector Gutierrez, Jamshed F. Kanga, Thomas Lahiri, (unknown), Bonnie W. Ramsey, Clement L. Ren, Michael S. Schechter, Wayne J. Morgan, Ronald L. Gibson, (unknown)	41
14	Improving the quality of care for patients with cystic fibrosis 2010 ·Current Opinion in Pediatrics ·Michael S. Schechter, Hector Gutierrez	32
15	Cystic fibrosis care in Chile 2009 ·Current Opinion in Pulmonary Medicine ·Hector Gutierrez, Ignacio Sánchez, Daniel V. Schidlow	9
16	Creating a Culture of Improvement 2008 ·Journal of Nursing Care Quality ·(unknown), (unknown), Hector Gutierrez	11
17	Unusually high prevalence rates of obesity in four Mexican rural communities 2001 ·European Journal of Clinical Nutrition ·(unknown), José Lara, (unknown), (unknown), Martha Escobar, Hector Gutierrez, A Chávez, W. P. T. James	38
18	Nitric oxide regulation of superoxide-dependent lung injury: Oxidant-protective actions of endogenously produced and exogenously administered nitric oxide 1996 ·Free Radical Biology and Medicine ·Hector Gutierrez, (unknown), Phillip Chumley, (unknown), Bruce Α. Freeman	103
19	Oxygen Radical-Nitric Oxide Reactions in Vascular Diseases 1995 ·Advances in pharmacology ·Bruce Α. Freeman, C. Roger White, Hector Gutierrez, Andrés Paler-Martı́nez, Margaret M. Tarpey, Homero Rubbo	58
20	The Use of Oral Hydration in the Treatment of Children with Acute Diarrhea in Primary Care 1989 ·Journal of Pediatric Gastroenterology and Nutrition ·(unknown), Ernesto Guiraldes, Tobias Hirsch, (unknown), (unknown), Hector Gutierrez, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact